Ayako Suzuki, MD, PhD

Associate Professor of Medicine
Campus mail Duke Box 3913, Durham, NC 27710
Phone (919) 684-2366
Email address ayako.suzuki@duke.edu

Education and Training

  • Fellow, Gastroenterology, Kanazawa University (Japan), 1989 - 1993
  • Resident, Medicine, Kanazawa University (Japan), 1987 - 1989
  • Ph.D., Kanazawa University (Japan), 1999
  • M.D., Kanazawa University (Japan), 1987

Publications

Shaar, Mohanad, Ayako Suzuki, Craig Poster, Gustaaf de Ridder, Xuefeng Zhang, Mary Kate Cronin, Shannon McCall, et al. “Serum Amyloid A (SAA) and C-Reactive Protein (CRP) Are Commonly Positive in Hepatocellular Carcinoma and Expression Levels Stratify According to Etiology and the Absence of Cirrhosis.” In Modern Pathology, 30:424A-425A. NATURE PUBLISHING GROUP, 2017.

Scholars@Duke

Yang, Ju Dong, Manal F. Abdelmalek, Cynthia D. Guy, Ryan M. Gill, Joel E. Lavine, Katherine Yates, Jagpal Klair, et al. “Patient Sex, Reproductive Status, and Synthetic Hormone Use Associate With Histologic Severity of Nonalcoholic Steatohepatitis.” Clin Gastroenterol Hepatol 15, no. 1 (January 2017): 127-131.e2. https://doi.org/10.1016/j.cgh.2016.07.034.

PMID
27523635
Full Text

Suzuki, Ayako, Horace J. Spencer, Cynthia A. Moylan, Jonathan A. Dranoff, Manal F. Abdelmalek, Cynthia D. Guy, and Anna Mae Diehl. “Hepatic estrogen transcriptional activity and estrogen receptor a gene expression are negatively correlated with fibrosis stage in patients with nonalcoholic fatty liver disease (NAFLD).” In Hepatology, 64:105A-105A. WILEY, 2016.

Scholars@Duke

Zhang, Jie, Utkarsh Doshi, Ayako Suzuki, Ching-Wei Chang, Jürgen Borlak, Albert P. Li, and Weida Tong. “Evaluation of multiple mechanism-based toxicity endpoints in primary cultured human hepatocytes for the identification of drugs with clinical hepatotoxicity: Results from 152 marketed drugs with known liver injury profiles.” Chem Biol Interact 255 (August 5, 2016): 3–11. https://doi.org/10.1016/j.cbi.2015.11.008.

PMID
26581450
Full Text

Klair, Jagpal Singh, Ju Dong Yang, Manal F. Abdelmalek, Cynthia D. Guy, Ryan M. Gill, Katherine Yates, Aynur Unalp-Arida, et al. “A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease.” Hepatology 64, no. 1 (July 2016): 85–91. https://doi.org/10.1002/hep.28514.

PMID
26919573
Full Text

Hunt, Christine M., Lauren A. Beste, Elliott Lowy, Ayako Suzuki, Cynthia A. Moylan, Hans L. Tillmann, George N. Ioannou, Joseph K. Lim, Michael J. Kelley, and Dawn Provenzale. “Veterans health administration hepatitis B testing and treatment with anti-CD20 antibody administration.” World J Gastroenterol 22, no. 19 (May 21, 2016): 4732–40. https://doi.org/10.3748/wjg.v22.i19.4732.

PMID
27217704
Full Text

Chen, Minjun, Ayako Suzuki, Shraddha Thakkar, Ke Yu, Chuchu Hu, and Weida Tong. “DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.” Drug Discov Today 21, no. 4 (April 2016): 648–53. https://doi.org/10.1016/j.drudis.2016.02.015.

PMID
26948801
Full Text

Suzuki, A., N. A. Yuen, K. Ilic, R. T. Miller, M. J. Reese, H. R. Brown, J. I. Ambroso, J. G. Falls, and C. M. Hunt. “Corrigendum to "Comedications alter drug-induced liver injury reporting frequency: Data mining in the WHO VigiBaseTM" [Regul. Toxicol. Pharmacol. (2015) 481-490] doi: 10.1016/j.yrtph.2015.05.004.” Regulatory Toxicology and Pharmacology 73, no. 1 (October 1, 2015): 348. https://doi.org/10.1016/j.yrtph.2015.07.020.

Full Text

Hunt, Christine M., Lauren A. Beste, George N. Ioannou, Elliott Lowy, Dawn T. Provenzale, Michael J. Kelley, Ayako Suzuki, et al. “Hepatitis B Testing Prior to Administration of Rituximab, Ofatumumab and Obinutuzumab in the National Veterans Affairs Health Healthcare System, 2002-2014.” In Hepatology, 62:478A-479A. WILEY-BLACKWELL, 2015.

Scholars@Duke

Pages